Who Owns Anaergia Company?

Anaergia Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who Owns Anaergia Inc.?

Understanding a company's ownership is key to grasping its strategic direction and market position. Anaergia Inc., a leader in waste-to-value solutions, has experienced significant ownership shifts, notably its 2021 IPO and a major 2024 investment.

Who Owns Anaergia Company?

Anaergia Inc., founded in 2007 and incorporated in Canada in 2010, focuses on converting organic waste into renewable natural gas and fertilizer. As of August 20, 2025, its market capitalization stands at approximately CAD 304.26 million.

Who holds the reins at Anaergia Inc.?

The ownership of Anaergia Inc. is characterized by a substantial stake held by a private investor and its founders. Public shareholders also comprise a portion of the ownership pie. This structure has evolved, particularly following the company's IPO in 2021 and a significant strategic investment by Marny Investissement SA in 2024. These events have reshaped the company's governance and financial landscape, impacting its operations and future growth, including its innovative Anaergia PESTEL Analysis.

Who Founded Anaergia?

Anaergia Inc. was established in 2007 by Dr. Andrew Benedek, an engineer with a Ph.D. in chemical engineering. Dr. Benedek's prior experience at ZENON Environmental, where he advanced membrane technologies for wastewater treatment, provided a strong foundation for Anaergia's focus on resource recovery.

Founder Dr. Andrew Benedek
Founding Year 2007
Initial Acquisition UTS (German pioneer in high solids digestion of agricultural waste)
Dr. Benedek's Roles Chairman of the Board (2021-2024), CEO (June 2014 - June 2023)
Early Ownership Status Principal shareholder with significant control via multiple voting shares
Icon

Founding Vision

The company's inception was driven by a vision for integrated waste-to-value solutions. This vision guided its technological development from the very beginning.

Icon

Technological Foundation

Anaergia's early strategy involved leveraging advancements from acquired European companies. This approach aimed to introduce high solids anaerobic digestion and resource recovery technologies to North America.

Icon

Founder's Influence

Dr. Andrew Benedek, as the founder and a principal shareholder, held significant influence over the company's early direction and operations.

Icon

Early Investment Landscape

Specific details regarding early angel investors or friends and family stakes during the initial phase are not publicly disclosed.

Icon

Control Mechanism

Dr. Benedek's initial ownership included multiple voting shares, which provided him with substantial control over the company's trajectory.

Icon

Market Entry Strategy

The company's initial focus was on bringing advanced digestion and resource recovery technologies to the North American market.

The foundational ownership of Anaergia Inc. is primarily attributed to its founder, Dr. Andrew Benedek. His extensive engineering background and prior success in commercializing membrane technologies laid the groundwork for the company's focus on resource recovery and advanced digestion processes. Dr. Benedek's significant stake, including multiple voting shares, ensured his substantial control during the company's formative years. The early strategy involved integrating and expanding upon existing European technologies, particularly in high solids digestion of agricultural waste, to establish a presence in North America. This approach to the Growth Strategy of Anaergia was central to its initial development.

Icon

Key Aspects of Early Ownership

Dr. Andrew Benedek's role as founder and principal shareholder was central to Anaergia's inception and early direction. His technical expertise and prior entrepreneurial success significantly shaped the company's technological focus and market entry strategy.

  • Dr. Benedek founded Anaergia in 2007.
  • He brought expertise from ZENON Environmental.
  • Early ownership involved significant control through multiple voting shares.
  • The company's strategy focused on acquiring and developing European technologies.
  • No public details exist on early angel or friends and family investors.

Anaergia SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has Anaergia’s Ownership Changed Over Time?

Anaergia Inc.'s ownership structure has seen significant evolution, most notably with its Initial Public Offering (IPO) in June 2021 and a subsequent strategic investment in 2024. These events have reshaped who owns Anaergia and its overall Anaergia stakeholders.

Event Date Impact on Ownership
IPO June 23, 2021 Offered 12,500,000 subordinate voting shares at C$14.00 per share, raising C$175 million.
Over-allotment Option Exercise July 20, 2021 Acquired an additional 1,740,500 shares, increasing gross proceeds to approximately C$199,367,000.
Marny Investissement SA Investment 2024 Marny Holdco Inc. invested C$40.8 million, acquiring over 60% of subordinate voting shares.
Share Conversion 2024 Dr. Andrew Benedek converted multiple voting shares to subordinate voting shares.

The journey of Anaergia Inc. ownership has been marked by key milestones that have significantly altered its shareholder landscape. The company's IPO on June 23, 2021, introduced public ownership, with 12,500,000 subordinate voting shares offered at C$14.00 each, generating C$175 million in gross proceeds. This was further bolstered by the partial exercise of an over-allotment option on July 20, 2021, adding 1,740,500 shares and bringing total gross proceeds to approximately C$199,367,000. The initial market capitalization at IPO was around CAD 784.07 million. A pivotal moment in Anaergia's ownership history occurred in 2024 with a strategic investment from Marny Investissement SA, through its subsidiary Marny Holdco Inc. This investment, totaling C$40.8 million across tranches, culminated on July 10, 2024, with Marny Holdco Inc. securing over 60% of Anaergia’s outstanding subordinate voting shares, representing approximately 60.9% of the voting rights on a non-diluted basis. This move was instrumental in addressing prior concerns about the company's ability to continue as a going concern. As of August 20, 2025, the Anaergia company major investors are primarily private companies, with MARNY S.A. holding about 55%. Insiders account for 26% of ownership, while the general public holds 16%. Institutional investors represent less than 5% of Anaergia's shares. Dr. Andrew Benedek, a principal shareholder, converted his multiple voting shares to subordinate voting shares as part of the Marny investment, simplifying the Anaergia company structure and eliminating dual-class shares. These changes have consolidated significant control with Marny Investissement SA, impacting the Anaergia company board of directors ownership and aligning shareholder interests.

Icon

Anaergia Ownership Breakdown (August 20, 2025)

Understanding the Anaergia company shareholding pattern reveals the current distribution of ownership among different groups.

  • Private Companies (primarily MARNY S.A.): Approximately 55%
  • Insiders: 26%
  • General Public: 16%
  • Institutional Investors: Less than 5%

Anaergia PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on Anaergia’s Board?

The board of directors for Anaergia Inc. has seen recent shifts, notably with the appointment of Ohad Epschtein as Executive Chairman in July 2024, representing Marny Holdco Inc. This change reflects a significant influence from Marny Investissement SA on the company's leadership and strategic direction.

Director Name Appointment Date Affiliation
Ohad Epschtein July 2024 Beneficial Owner, Nominee of Marny Holdco Inc.
Dr. Andrew Benedek (Continuing) Director
Dr. Mourato Benedek 2007 Director
Peter Gross 2019 Director
Ronen Kantor February 2024 Nominee of Marny
Assaf Onn April 2024 CEO, Nominee of Marny
Stan Simmons (Not specified) Director

A pivotal governance change for Anaergia Inc. occurred in Q3 2024 with the discontinuation of its dual-class share structure. This move, finalized around August 2024, saw all multiple voting shares converted into subordinate voting shares, which were then reclassified as common shares. This transition established a uniform one-share-one-vote system. Despite this standardization, Marny Holdco Inc. now commands over 60% of the total voting rights, granting it substantial control over the company's future strategies and key decisions.

Icon

Anaergia's Evolving Shareholder Landscape

Anaergia's ownership structure has undergone significant transformation, culminating in a concentration of voting power. Marny Holdco Inc. has emerged as the majority shareholder, influencing key leadership appointments.

  • Marny Holdco Inc. holds over 60% of voting rights.
  • The dual-class share structure was eliminated in Q3 2024.
  • All multiple voting shares were converted to common shares.
  • This established a one-share-one-vote system.
  • Key leadership roles are now held by Marny nominees.

Anaergia Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped Anaergia’s Ownership Landscape?

Over the past few years, Anaergia's ownership structure has seen significant transformations, notably with a substantial strategic investment that has reshaped its shareholder landscape. These changes reflect the company's evolving growth strategy and operational focus.

Event Date Details
Bought Deal Offering April 2022 Gross proceeds of C$60 million from subordinate voting shares for growth strategy.
Strategic Investment Agreement December 2023 Agreement for a C$40.8 million equity investment from Marny Investissement SA.
First Tranche Closing February 2024 C$12.5 million equity investment.
Second Tranche Closing April 2024 C$13.6 million equity investment.
Third Tranche Closing July 10, 2024 C$14.7 million equity investment; Marny Holdco Inc. becomes controlling shareholder (>60%).
Share Structure Reclassification August 2024 Elimination of dual-class share structure, converting all subordinate voting shares to common shares.

The strategic investment by Marny Investissement SA, executed through Marny Holdco Inc., has fundamentally altered Anaergia's ownership, establishing it as the controlling shareholder with over 60% of the subordinate voting shares as of July 10, 2024. This shift was further solidified by the subsequent elimination of the dual-class share structure in August 2024, unifying the company's share classes. Key leadership changes accompanied this transition, with Marny nominees Ohad Epschtein appointed Executive Chairman and Assaf Onn appointed CEO. This concentration of ownership contrasts with broader industry trends favoring institutional investment; as of August 20, 2025, Anaergia's institutional holdings remain below 5%. The company's strategic direction is now firmly set on becoming a leading renewable fuel producer, a goal supported by the improved project pipeline and the mitigating of 'going concern' doubts, as noted in Q3 2024. Understanding these ownership dynamics is crucial for assessing Anaergia's future trajectory and its Mission, Vision & Core Values of Anaergia.

Icon Majority Ownership Shift

Marny Holdco Inc. secured majority control of Anaergia in July 2024. This concentration of ownership marks a significant change in the company's shareholder pattern.

Icon Leadership and Strategy Alignment

New leadership appointments from the majority investor signal a focused strategy on renewable fuel production. This aligns with the company's stated objectives.

Icon Share Structure Standardization

The August 2024 reclassification eliminated the dual-class share structure. This move standardized voting rights across all common shares.

Icon Institutional Holdings Trend

Anaergia's institutional investor base remains relatively small, below 5% as of August 2025. This is a notable point compared to general market trends.

Anaergia Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.